STAT Plus: The coronavirus pandemic is reigniting a fierce debate over compounded drugs
TONY DEJAK/AP
Hoping to alleviate issues wrought by the coronavirus, the FDA drastically rolled back its oversight of compounding pharmacies.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario